Catalyst Wire Dossier Catalyst Wire Dossier

Bemnifosbuvir

bemnifosbuvir · Atea Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

7 regulatory and trial events tracked for Bemnifosbuvir, covering 2024-07-31 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Drug-drug Interaction Study of Bemnifosbuvir/Ruzasvir (BEM/RZR) and Ethinyl Estradiol/Levonorgestrel (EE/LNG) [Phase 1]

See pricing